-
09/23/24 Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations
Summary COVID-19 vaccine recommendations For most people, the minimum interval between their last 2023–2024 COVID-19 vaccine dose and their 2024–2025 COVID-19 vaccine dose is 8 weeks. There are exceptions for people completing a multidose initial vaccination series, including: Learn more in CDC’s detailed vaccination schedules for people who are not moderately or severely immunocompromised and people who are…
-
05/23/24 Health Advisory: Pertussis Increasing in Washington
Summary Current situation in Washington In 2023 CDC (Centers for Disease Control and Prevention) week 1–18, healthcare providers reported 24 cases of confirmed or probable pertussis in Washington. In this same period in 2024, providers reported 170 cases. This is a 6-fold increase. Multiple health jurisdictions reported increases. DOH (Washington State Department of Health) updates its weekly pertussis update every Friday. Recommendations for…
-
04/30/24 Health Advisory: Invasive Serogroup Y Meningococcal Disease Increasing in the United States
Summary Invasive serogroup Y meningococcal disease cases are on the rise in the United States. Cases are disproportionately occurring in people who are: 30–60 years old. Black or African American. Living with HIV. Washington has not seen an increase in cases. Patients with invasive meningococcal disease may have bloodstream infection or septic arthritis, without typical meningitis symptoms…
-
03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World
Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the United States, and around the world in 2024. Outbreaks often start when an unvaccinated or under-vaccinated person is exposed during international travel and…
-
02/08/24 Health Advisory: RSV Prevention Updates
Summary Background On Oct. 23, 2023, Centers for Disease Control and Prevention (CDC) issued a health alert about the limited supply of nirsevimab. CDC recommended healthcare providers prioritize nirsevimab for infants born later in RSV (respiratory syncytial virus) season or for those at increased risk for severe illness. On Jan. 5, 2024, CDC issued updated guidance about the increased…
-
01/19/24 Health Advisory: Measles Outbreak in Southwest Washington
An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers…
-
12/13/23 Health Advisory: Test for tuberculosis people who were incarcerated
A large outbreak of tuberculosis (TB) in the state prison system may affect more than 800 people who were incarcerated. Requested actions Ask patients about risk factors for TB exposure: Test people with risk factors unless they have a known history of TB infection or TB disease. Evaluate people who test positive to rule out…
-
12/06/23 Health Advisory: Test perinatally exposed children for hepatitis C.
Action requested Centers for Disease Control and Prevention (CDC) recommends you test children born to people with: Test children for HCV RNA at 2–6 months old, up to 17 months old. Give untested children older than 18 months an HCV antibody test with reflex to HCV RNA. Report hepatitis C cases in pregnant people and the…
-
11/21/23 Health Advisory: Nirsevimab supplies are short.
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNirsevimab (Beyfortus) RSV preventive antibodies for infants is in short supply. Encourage Abrysvo vaccine for pregnant people to protect babies from RSV. Washington will receive 7,700 50 mg and 600 100 mg nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. Centers for Disease Control and Prevention (CDC) released a Health Alert that…
-
10/16/23 Health Advisory: FDA Authorized New Novavax COVID-19 Vaccine Formulation
Advisory or Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesThe new adjuvanted (2023–2204) formulation of Novavax COVID-19 vaccine is authorized for people 12 years or older as follows: Updated 2023–2024 COVID-19 vaccine availability may be limited and vary by location. Help patients understand this situation and thank them for their patience. Resources Questions?
-
09/28/23 Health Advisory: 2023–2024 Respiratory Illness Season
Communicable Disease and Immunization Update, COVID-19, Influenza, News and Alerts, Provider ResourcesThis 2023–2024 respiratory illness season, we’re monitoring 3 common causes of respiratory illness that circulate in Pierce County: influenza, respiratory syncytial virus (RSV), and COVID-19. Influenza Centers for Disease Control and Prevention (CDC) estimates that in the United States last flu season (2022–2023) caused: Those at highest risk for severe illness include: Guidelines RSV RSV…
-
09/26/23: Regional healthcare organizations adopt masking guidelines
Healthcare facilities in the region have joined together voluntarily to prioritize the health and safety of patients and employees by adopting interim thresholds for universal masking in hospitals and outpatient clinics. When thresholds are crossed, which indicates increased regional respiratory illness activity and impact, masking by staff and patients will be required in patient care…
-
09/19/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized
On Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. On Sept. 12, 2023, Centers for Disease Control and Prevention (CDC) recommended everyone 6 months or older get new, updated (2023–2024) COVID-19 vaccine. The federal government will no longer provide COVID-19 vaccine.…